Exiqon AS - Product Pipeline Analysis, 2017 Update

Date: June 8, 2017
Pages: 32
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E7FAF25DAD5EN
Leaflet:

Download PDF Leaflet

Exiqon AS - Product Pipeline Analysis, 2017 Update
Summary

Exiqon A/S (Exiqon), a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company’s product categories include microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products. Its microRNA research products comprise RNA isolation kits, microRNA sequencing kits, microRNA microarray analysis, universal RT microRNA PCR, microRNA detection probes, ISH detection probes and ISH kits, and functional analysis. Exiqon offers services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service. The company’s products find applications in isolation, microarray analysis, northern blotting, real-time PCR, in situ hybridization, functional analysis and SNP detection. It operates in Denmark and the US. Exiqon is headquartered in Vedbaek, Denmark.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Exiqon AS
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Exiqon A/S Company Overview
Exiqon A/S Company Snapshot
Exiqon A/S Pipeline Products and Ongoing Clinical Trials Overview
Exiqon A/S – Pipeline Analysis Overview
Exiqon A/S - Key Facts
Exiqon A/S - Major Products and Services
Exiqon A/S Pipeline Products by Development Stage
Exiqon A/S Pipeline Products Overview
Colon Cancer Test - Stage III And IV Patient
Colon Cancer Test - Stage III And IV Patient Product Overview
Diagnostic Test - Prostate Cancer Stratification
Diagnostic Test - Prostate Cancer Stratification Product Overview
Diagnostic Test - T-Cell Lymphoma
Diagnostic Test - T-Cell Lymphoma Product Overview
Genetic Test - Prostate Cancer
Genetic Test - Prostate Cancer Product Overview
miRNA Biomarker - Cancer of Unknown Primary
miRNA Biomarker - Cancer of Unknown Primary Product Overview
miRNA Test - Endometrial Cancer
miRNA Test - Endometrial Cancer Product Overview
miRNA Test - Lung Cancer
miRNA Test - Lung Cancer Product Overview
miRNA test - Ovarian Cancer
miRNA test - Ovarian Cancer Product Overview
Prognosis Test - Prostate Cancer
Prognosis Test - Prostate Cancer Product Overview
Prostate Cancer - Early Detection Test
Prostate Cancer - Early Detection Test Product Overview
Exiqon A/S - Key Competitors
Exiqon A/S - Key Employees
Exiqon A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exiqon A/S, Recent Developments
Jul 13, 2016: Nasdaq Copenhagen accepts Exiqon request for delisting and cancellation from trading of the Exiqon shares
Jul 04, 2016: Exiqon – Nomination of candidates for the supervisory board
Apr 26, 2016: Exiqon: First Quarter 2016 Supports Continued Strong Momentum
Feb 08, 2016: Exiqon realizes full year 2015 profitability driven by strong revenue growth
Nov 06, 2015: Accelerated RNA discovery by XploreRNA presented to audience at Genome Festival
Oct 26, 2015: Third consecutive profitable quarter with continued strong growth
Aug 25, 2015: Exiqon: Continued strong performance in the second quarter with 24% growth and profitability
Jun 30, 2015: Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA
Jun 30, 2015: Exiqon launches ExiLERATE LNA qPCR product portfolio for analysis of mRNA and lncRNA
Dec 18, 2014: Exiqon launches new Research Use Only kit for PCR analysis of colon cancer samples
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Exiqon A/S Pipeline Products and Ongoing Clinical Trials Overview
Exiqon A/S Pipeline Products by Equipment Type
Exiqon A/S Pipeline Products by Indication
Exiqon A/S, Key Facts
Exiqon A/S, Major Products and Services
Exiqon A/S Number of Pipeline Products by Development Stage
Exiqon A/S Pipeline Products Summary by Development Stage
Colon Cancer Test - Stage III And IV Patient - Product Status
Colon Cancer Test - Stage III And IV Patient - Product Description
Diagnostic Test - Prostate Cancer Stratification - Product Status
Diagnostic Test - Prostate Cancer Stratification - Product Description
Diagnostic Test - T-Cell Lymphoma - Product Status
Diagnostic Test - T-Cell Lymphoma - Product Description
Genetic Test - Prostate Cancer - Product Status
Genetic Test - Prostate Cancer - Product Description
miRNA Biomarker - Cancer of Unknown Primary - Product Status
miRNA Biomarker - Cancer of Unknown Primary - Product Description
miRNA Test - Endometrial Cancer - Product Status
miRNA Test - Endometrial Cancer - Product Description
miRNA Test - Lung Cancer - Product Status
miRNA Test - Lung Cancer - Product Description
miRNA test - Ovarian Cancer - Product Status
miRNA test - Ovarian Cancer - Product Description
Prognosis Test - Prostate Cancer - Product Status
Prognosis Test - Prostate Cancer - Product Description
Prostate Cancer - Early Detection Test - Product Status
Prostate Cancer - Early Detection Test - Product Description
Exiqon A/S, Key Employees
Exiqon A/S, Subsidiaries
Glossary

LIST OF FIGURES

Exiqon A/S Pipeline Products by Equipment Type
Exiqon A/S Pipeline Products by Development Stage

COMPANIES MENTIONED

Zealand Pharma AS
Genmab A/S
BioPorto Diagnostics A/S
Skip to top


Ask Your Question

Exiqon AS - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: